A clinical trial has begun which will use stem cell transplants to grow a new immune system for people with untreatable Crohn’s disease – a painful and chronic intestinal disease which affects at least 115,000 people in the UK.
The study, led by Queen Mary University of London and Barts Health NHS Trust, is funded with £2m from a Medical Research Council and National Institute for Health Research partnership, and will be recruiting patients from centres in Cambridge, Edinburgh, Liverpool, London, Nottingham, Oxford and Sheffield. The trial is coordinated through the Clinical Trials Unit at the University of Sheffield.
Crohn’s disease is a long-term condition that causes inflammation of the lining of the digestive system, and results in diarrhoea, abdominal pain, extreme tiredness and other symptoms that significantly affect quality of life.
Current treatments include drugs to reduce inflammation but these have varying results, and surgery is often needed to remove the affected part of the bowel. In extreme cases, after multiple operations over the years, patients may require a final operation to divert the bowel from the anus to an opening in the stomach, called a stoma, where stools are collected in a pouch.
‘We might be able to radically alter the course of the disease’
Chief investigator Professor James Lindsay from Queen Mary’s Blizard Institute and a consultant at Barts Health NHS Trust said: “Despite the introduction of new drugs, there are still many patients who don’t respond, or gradually lose response, to all available treatments. Although surgery with the formation of a stoma may be an option that allows patients to return to normal daily activities, it is not suitable in some and others may not want to consider this approach.
“We’re hoping that by completely resetting the patient’s immune system through a stem cell transplant, we might be able to radically alter the course of the disease. While it may not be a cure, it may allow some patients to finally respond to drugs which previously did not work.”
Helen Bartlett, a Crohn’s disease patient who had stem cell therapy at John Radcliffe Hospital, Oxford, said: “Living with Crohn’s is a daily struggle. You go to the toilet so often, you bleed a lot and it’s incredibly tiring. You also always need to be careful about where you go. I’ve had to get off trains before because there’s been no toilet, and I needed to go there and then.
“I’ve been in and out of hospital for the last twenty years, operation after operation, drug after drug, to try to beat this disease. It’s frustrating, it’s depressing and you just feel so low.
“When offered the stem cell transplant, it was a complete no brainer as I didn’t want to go through yet more failed operations. I cannot describe how much better I feel since the treatment. I still have problems and I’m always going to have problems, but I’m not in that constant pain.”
Giving patients a new immune system
The Latest on: Crohn’s disease
via Google News
The Latest on: Crohn’s disease
- Opinion: Crohn’s, COVID-19, and the current crisison March 22, 2020 at 7:22 pm
I was diagnosed with Crohn’s disease, a digestive illness, during my sophomore year of high school. Inflammatory Bowel Diseases occur when the body’s immune system works in overdrive to protect the ...
- Jack Leach, who suffers from Crohn's disease, reveals coronavirus fearon March 21, 2020 at 3:30 pm
He is, he says, 'just trying to do the right thing'. Leach, who is 28, was diagnosed with Crohn's disease, which causes inflammation of the digestive system, at the age of 14, and has been on and off ...
- Cavaliers' Larry Nance Says Crohn's Disease Makes Him Vulnerable to COVID-19on March 20, 2020 at 1:54 pm
Cleveland Cavaliers center Larry Nance Jr. is at greater risk of contracting the coronavirus because of his Crohn's disease, which is treated with immunosuppressive medication, Nance told Kelsey Russo ...
- Larry Nance Jr. takes precautions for COVID-19 as he manages Crohn’s diseaseon March 20, 2020 at 11:38 am
These are cookies that are required to provide you with features or services that you have requested. For example, Cookies that enable you to log into secure areas of our site or use a shopping cart.
- Global IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market 2020 Industry Segmentation, CAGR Status, Leading Trends, Forecast to 2025on March 20, 2020 at 2:59 am
Currently published by Fior Markets is a contemporary illuminating report title Global IBD (Ulcerative Colitis and Crohn’s Disease) Treatment Market 2020 by Manufacturers, Regions, Type and ...
- JAK–STAT pathway targeting for the treatment of inflammatory bowel diseaseon March 19, 2020 at 6:44 am
The biological effects of cytokines in intestinal homeostasis and disease occur as a result of JAK–STAT signalling. This Review describes the current understanding of JAK–STAT signalling in intestinal ...
- Understanding the Remission and Relapse Cycle in Crohn’s Diseaseon March 18, 2020 at 10:18 am
Crohn’s disease is a disorder that causes irritation and swelling in the lining of the digestive tract (also called the gastrointestinal tract, or GI tract). Inflammation from Crohn’s disease can ...
- Crohn’s Disease Medications and Treatmentson March 18, 2020 at 10:14 am
Crohn’s disease is an autoimmune disorder that affects the gastrointestinal (GI) tract. According to the Crohn’s and Colitis Foundation, it’s one of the conditions that make up irritable bowel ...
- Serum biomarker panel may help predict Crohn’s diagnosison March 18, 2020 at 8:29 am
A panel of serum antibodies and proteins helped identify patients who later received a diagnosis of Crohn’s disease within 5 years, according to research published in Gastroenterology. Jean-Frederic ...
via Bing News